We are live on
!
Find out more
BCWM
Ball & Co Wealth Management Portfolio holdings
AUM
$141M
1-Year Est. Return
21.84%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+21.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
–
Cap. Flow
+$128M
Cap. Flow
% of AUM
101.61%
Top 10 Holdings %
Top 10 Hldgs %
95.71%
Holding
74
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$36.9M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$33.4M |
| 3 |
Alerian MLP ETF
AMLP
|
+$13.9M |
| 4 |
Capital Group Dividend Value ETF
CGDV
|
+$10.4M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$9.73M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.98% |
| 2 | Technology | 0.78% |
| 3 | Communication Services | 0.52% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Consumer Staples | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zoetis
ZTS
$31.2B
| $7K | 0.01% |
+48
| New | +$8.58K |
|
52
Amplify Blockchain Technology ETF
BLOK
$1.08B
| $4K | ﹤0.01% |
+101
| New | +$4.54K |
|
53
Hexcel
HXL
$7.89B
| $4K | ﹤0.01% |
+76
| New | +$4.7K |
|
|
ONCY
54
Oncolytics Biotech
ONCY
$95.1M
| $4K | ﹤0.01% |
+4,393
| New | +$4.57K |
|
55
Pfizer
PFE
$147B
| $4K | ﹤0.01% |
+175
| New | +$4.75K |
|
56
Viking Therapeutics
VKTX
$3.91B
| $4K | ﹤0.01% |
+100
| New | +$5.7K |
|
57
Johnson & Johnson
JNJ
$621B
| $3K | ﹤0.01% |
+22
| New | +$3.41K |
|
58
Eli Lilly
LLY
$1.04T
| $3K | ﹤0.01% |
+5
| New | +$4.14K |
|
59
Merck
MRK
$317B
| $3K | ﹤0.01% |
+30
| New | +$3.09K |
|
60
Carnival Corporation Ltd
CCL
$40.6B
| $2K | ﹤0.01% |
+100
| New | +$2.34K |
|
61
Allogene Therapeutics
ALLO
$673M
| $1K | ﹤0.01% |
+500
| New | +$1.23K |
|
62
Brighthouse Financial
BHF
$3.55B
| $1K | ﹤0.01% |
+26
| New | +$1.27K |
|
63
Comcast
CMCSA
$87.8B
| $1K | ﹤0.01% |
+41
| New | +$1.7K |
|
64
EOG Resources
EOG
$71.5B
| $1K | ﹤0.01% |
+15
| New | +$1.92K |
|
65
iShares Core S&P Total US Stock Market ETF
ITOT
$97.3B
| $1K | ﹤0.01% |
+8
| New | +$1.04K |
|
66
iShares Core S&P 500 ETF
IVV
$898B
| $1K | ﹤0.01% |
+3
| New | +$1.78K |
|
67
BRC Inc
BRCC
$118M
| $0 | ﹤0.01% |
+38
| New | +$119 |
|
68
Corteva
CTVA
$52.5B
| $0 | ﹤0.01% |
+6
| New | +$355 |
|
69
DuPont de Nemours
DD
$19.9B
| $0 | ﹤0.01% |
+5
| New | +$520 |
|
70
Dow Inc
DOW
$21.4B
| $0 | ﹤0.01% |
+7
| New | +$327 |
|
71
PureCycle Technologies
PCT
$1.38B
| $0 | ﹤0.01% |
+39
| New | +$453 |
|
72
Constellation Brands
STZ
$22.3B
| $0 | ﹤0.01% |
+4
| New | +$950 |
|
73
Viatris
VTRS
$20.6B
| $0 | ﹤0.01% |
+20
| New | +$246 |
|
74
Warner Bros
WBD
$65.1B
| $0 | ﹤0.01% |
+33
| New | +$307 |
|
Similar funds
WA
OFA
SFS
MFG
MCAV
MCM
OFG
CL
Ball & Co Wealth Management's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Ball & Co Wealth Management, which disclosed 74 positions worth $126M. Its ten largest holdings account for 96% of the portfolio.
Its largest position is iShares Russell 1000 Growth ETF: 374,856 shares worth $37.6M.
By sector, the portfolio is most concentrated in Healthcare at 4% of assets, followed by Technology and Communication Services.
- Ball & Co Wealth Management's largest Q4 2024 buy was iShares Russell 1000 Growth ETF: 374,856 shares worth $37.6M.
- Ball & Co Wealth Management's ten largest holdings make up 96% of its $126M portfolio in Q4 2024.
- Ball & Co Wealth Management disclosed 74 positions in Q4 2024, its first 13F filing on record.
Based on Ball & Co Wealth Management's 13F filing for Q4 2024, filed 20 Feb 2025.